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Abstract
Background: Early diagnosis of osteoarthritis (OA) is difficult. Cartilage oligomeric matrix protein (COMP) and
crosslinked C-telopeptides of type II collagen (CTX-II) are two markers which can potentially predict the destruction
of articular cartilage of early OA. To comprehensively evaluate the diagnosis value of serum COMP and CTX-II
markers in OA, the longitudinal and combined measurement of serum COMP and CTX-II were performed at
different stages of pathological process of OA in adult rabbits with OA, compared with the sham-operated rabbits.
Methods: Thirty-six adult white rabbits were randomly divided into two groups, the OA group and the control
group (n = 18 per group). OA models were established by anterior cruciate ligament transection. Sham operations
were performed in the control group. Before the surgery and at weeks 2, 4, 6, 8, 10, and 12 after surgery, serum
CTX-II and COMP concentrations were detected using sandwich-ELISA in all rabbits. Three rabbits in each group
were killed at weeks 2, 4, 6, 8, 10, and 12 after surgery, and femoral condyle specimens were collected. Histological
changes in articular cartilage were evaluated according to the Mankin scoring criteria.
Results: At each time point, the Mankin scores and serum concentrations of CTX-II and COMP were significantly
higher in the OA group than in the control group. In addition, in the OA group, there was a significant relationship
between the CTX-II and COMP concentrations and the Mankin score.
Conclusions: Early dynamic combined detection of serum CTX-II and COMP concentrations is effective for early OA
diagnosis and evaluation of OA severity.
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Background
Osteoarthritis (OA) is one of the most common bone
and joint aging diseases; it can cause joint pain and dis-
ability [1]. Approximately 9.29% of the US population is
diagnosed with symptomatic knee OA by 60 years of
age [2]. However, the etiology and pathogenesis of OA
are still unclear and it is still an incurable disease [3].
There are no sensitive diagnostic techniques other
than classical radiography; accordingly, OA is often
not detected until the middle or end stage [4, 5].
Owing to the absence of disease-modifying treatments,
joint replacement is the only effective treatment for
end-stage OA; other treatments cannot effectively alle-
viate pain or improve joint function [4–6]. The earlier
OA is diagnosed and treated, the better the prognosis.
Therefore, there is an urgent need to develop tech-
niques that are more effective than radiography in
clinical practice.
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Some structural molecules and fragments derived from
bone, articular cartilage, and the synovium, all of which
are affected by OA, are candidate OA biomarkers [7–11].
Cartilage oligomeric matrix protein (COMP) and cross-
linked C-telopeptides of type II collagen (CTX-II) are two
biochemical markers; they are degradation products of
joint tissues, especially the cartilage extracellular matrix,
and can potentially predict the destruction of articular
cartilage in OA [12–15]. However, many studies of early
OA diagnosis have only measured one of these two bio-
markers at a single time point during the pathological
process of OA.
To evaluate the diagnostic value of serum COMP and
CTX-II markers in OA comprehensively, a longitudinal
analysis of the combined measurement of serum
COMP and CTX-II was performed during the patho-
logical process in adult rabbits with OA, using rabbits
that received a sham operation as controls. In addition,
the relationships between COMP and CTX-II concen-




Thirty-six healthy mature white rabbits (2.14–2.58 kg,
11–12 months old, 18 males and 18 females) were ob-
tained from the Animal Experimental Center at Xi’an
Jiaotong University. None of the rabbits was adminis-
tered any medication or used in any previous experi-
ment. The animals were acclimatized for at least
1 week before the start of the experiment. The rabbits
were randomly divided into two groups, the control
and OA groups (18 rabbits per group). Before the oper-
ation, 3% sodium pentobarbital (1 mL/kg) were injected
intraperitoneally to the rabbits for anesthesia. All rab-
bits in the OA group underwent anterior cruciate liga-
ment transection (ACLT) in their left hind knees under
arthroscopy to induce OA [16]. The same surgical tech-
niques except for ACLT were applied to the rabbits of
the control group. After the operation, all rabbits in the
two groups acted freely in cages, and their health status
were observed twice daily. This study was approved by
the Animal Care and Use Committee of Xi’an Jiaotong
University.
Serum collection and storage
Before surgery and at weeks 2, 4, 6, 8, 10, and 12 after
surgery, 5 mL of blood was drawn from the ear margin
vein of each rabbit in the control and OA groups. The
blood was centrifuged for 15 min at 1000×g at room
temperature. The supernatant was collected, divided,
and stored at −80 °C until use (≤6 months). Blood col-
lection tubes were disposable and non-pyrogenic and
did not contain endotoxins.
Tissue collection and histological analysis
At 2, 4, 6, 8, 10, and 12 weeks after surgery, three rabbits
in each group were randomly selected and were admin-
istered euthanasia. The medial femoral condyles were
cut from all rabbits and fixed in 10% buffered formalin
for 72 h. Then the tissues were decalcified with 10%
EDTA solution (pH = 7.4) on a 48-h/48-h/72-h cycle for
approximately 10 weeks. After decalcification, the tissues
were dehydrated in a graded series of ethanol and xylol
and subsequently embedded in paraffin. For hematoxylin
and eosin (HE) staining and toluidine O-staining, the
paraffin tissue blocks were sectioned (5 μm). All sections
were stained in a single batch. The histopathology
changes in articular cartilage were assessed in stained
sections according to the OA Histological Histochemical
Grading System (HHGS) introduced by Mankin et al.
[17]. A pathologist who did not know the grouping eval-
uated all the sections.
Analysis of serum CTX-II and COMP concentrations
The serum CTX-II concentrations of animals in each
group were also measured using the quantitative sand-
wich enzyme immunoassay technique (Rabbit CTX-II
ELISA Kit, Cusabio Biotech Co., Ltd., College Park, MD,
USA). Standard or sample (100 μL) was added to each
well, and the plate was covered and incubated for 2 h at
37 °C. The liquid in each well was removed and 100 μL
of anti-biotin antibody was added to each well. The plate
was covered and incubated for 1 h at 37 °C. Then, each
well was washed with Wash Buffer three times, 100 μL
of HRP-avidin was added to each well, and the plate was
covered and incubated for 1 h at 37 °C. Each well was
washed with Wash Buffer five times, 90 μL of TMB sub-
strate was added to each well, and the plate was incu-
bated for 15–30 min at 37 °C. Subsequently, 50 mL of
Stop Solution was added to each well. The optical dens-
ity (OD) of each well was determined within 5 min using
a microplate reader at 450 nm. The CTX-II concentra-
tion was calculated by comparing the OD of each sample
to the standard curve.
The serum COMP concentration of each group was
measured using the sandwich enzyme-linked immuno-
sorbent assay (Rabbit COMP ELISA Kit, Elab science
Biotechnology Co., Ltd., Wuhan, China). Standard or
sample (100 μL) was added to each well, and the plate
was covered and incubated for 90 min at 37 °C. Then,
the liquid in each well was removed and 100 μL of Bio-
tinylated Detection Ab Working Solution was added to
each well. The plate was covered and incubated for 1 h
at 37 °C. Then, each well was washed with Wash Buffer
three times, 100 μL of HRP-conjugate working solution
was added to each well, and the plate was covered and
incubated for 30 min at 37 °C. Each well was washed
with Wash Buffer five times, 90 μL of Substrate Solution
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was added to each well, and the plate was covered and
incubated for 15 min at 37 °C. Then, 50 μL of Stop Solu-
tion was added to each well. The OD value of each well
was determined immediately using a microplate reader
at a wavelength of 450 nm. The COMP concentration
was calculated using the standard curve.
Statistical analysis
The data are expressed as means ± standard deviation
(SD). All statistical analyses were implemented in SPSS
13.0. The Mann–Whitney test was utilized to examine
differences in the Mankin scores and the serum concen-
trations of COMP and CTX-II between the control and
OA groups. Correlations were analyzed using Spearman’s




In the control group, the slices of HE staining exhibited
a smooth and intact surface of articular cartilage. In
addition, the chondrocytes in the middle zone were or-
ganized and the staining of matrix was homogeneous
(Fig. 1a). However, in the OA group, the different mani-
festations of articular cartilage were observed at various
stages. At week 2 after surgery, the articular cartilage
surface showed also smooth and intact. However, the
chondrocyte in the superficial zone distributed unequally
(Fig. 1b). At week 4 after surgery, the articular cartilage
surface became unsmooth and the chondrocytes in the
middle zone were disorganized (Fig. 1c). At week 6 after
surgery, the articular surface showed completely rough,
and the chondrocytes in the middle and deep zones were
completely disorganized (Fig. 1d). At week 8 after sur-
gery, proliferative chondrocyte clusters emerged in the
superficial zone (Fig. 1e). At week 10 after surgery,
proliferative chondrocyte clusters became noted in the
superficial and middle zones. The matrix showed a loss
of staining (Fig. 1f ). At week 12 after surgery, vertical
clefts in the calcified zone were found in some
specimens. Cell loss was noted in the middle and deep
zones (Fig. 1g). The Mankin scores are shown in Fig. 2.
Within each time point, the Mankin scores in the OA
group were significantly higher than those in the control
group were (P < 0.05). The Mankin scores of the OA
group increased as OA progressed.
CTX-II and COMP concentrations
The concentration of CTX-II in rabbits of the control
and OA groups at various time points are summarized
in Fig. 3. The CTX-II concentration in the OA group
was higher than that in the control group (P < 0.05).
Similarly, the COMP concentrations of rabbits in the
control and OA groups at various time points are sum-
marized in Fig. 4. The COMP concentration was higher
in the OA group than in the control group (P < 0.05).
In addition, the concentrations of serum CTX-II and
COMP increased in the OA group with the progression
of OA. There was a positive correlation between the
serum CTX-II concentration and serum COMP con-
centration (r = 0.823, P < 0.001) (Fig. 5).
Correlation between the serum concentrations of COMP
and CTX-II and the Mankin score of the corresponding
articular cartilage
There was a positive correlation between the serum
concentration of CTX-II and the Mankin score of the
corresponding articular cartilage (r = 0.882, P < 0.001)
(Fig. 6). Similarly, there was a positive relationship
between the serum concentration of COMP and the
Mankin score of the corresponding articular cartilage
(r = 0.798, P < 0.001) (Fig. 7).
Discussion
In this study, our main aim was to investigate the diag-
nostic value of CTX-II and COMP at the early stage of
OA. The degeneration of articular cartilage, including
the degeneration of cartilage cells and matrix, is the
main pathological characteristic of OA [18]. However,
matrix degeneration mainly results in the losses of
Fig. 1 Hematoxylin and eosin (HE) staining of articular cartilage of rabbits in two groups (magnification: ×10). a Control. b Week 2 after surgery.
c Week 4 after surgery. d Week 6 after surgery. e Week 8 after surgery. f Week 10 after surgery. g Week 12 after surgery
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proteoglycans and type II collagen. CTX-II is one of the
main products of type II collagen degeneration. When
type II collagen is degraded, CTX-II is released into the
synovial fluid and absorbed by the serum. COMP, a tissue-
specific protein, binds to type II collagen fibers and can
stabilize the collagen fiber network of articular cartilage.
When the articular cartilage is destroyed, COMP is
released into the synovial fluid and absorbed by the
serum. Accordingly, the serum levels of CTX-II and
COMP reflect the metabolism of type II collagen fibers.
Tang et al. [19] found that the serum levels of CTX-II
were significantly higher in patients with Kashin–Beck
disease (KBD) or OA than in healthy adults. In our
study, the serum concentration of CTX-II was higher in
the OA group than in the control group at all time
points after surgery. We found that the serum concen-
tration of CTX-II increased beginning as early as week 2
after surgery. The same results have been obtained in
rabbits with OA induced by ACLT in a previous study
[12]. These results suggest that type II collagen fibers
are destroyed at a very early stage of OA development.
This inference is supported by our histological results,
which indicated that there was minor damage in the ar-
ticular cartilage of the OA group at week 2 after surgery.
We also found that the serum concentration of CTX-II
increased over time in the OA group. The same results
have been obtained in previous studies [12, 20]. These
results indicate that articular cartilage damage increased
over time in the OA group. We also found that the in-
crease in the CTX-II concentration was gradual, and the
apparent peak was not detected at 12 weeks. However,
an obvious peak was observed during the first 3 weeks
following surgery in the study of Duclos et al. [20]. They
inferred that the joint response was associated with post-
operative inflammation owing to chirurgical alterations,
which could influence cartilage collagen turnover. In this
study, the operation was performed under arthroscopy,
with slight surgical injury to the joint such that the im-
pact to the balance structure of the joint was negligible.
Therefore, the joint response was mild and no obvious
peak was detected.
To investigate the correlation between the CTX-II
concentration and the severity of articular cartilage de-
generation, histological changes in the articular cartilage
at various time points were evaluated based on the
Mankin scoring system. We found that within each time
point, the Mankin scores of the corresponding articular
cartilage in the OA group were significantly higher than
those in the control group. It indicated that the OA
model induced in this study was effective. In this OA
model, articular cartilage degeneration was a slow and
gradual process, in accord with real histological pro-
cesses of OA. We also found that the serum CTX-II
concentration was positively correlated with the Mankin
score of the corresponding articular cartilage in the OA
group during the 12-week study. Higher serum CTX-II
concentrations were associated with higher articular car-
tilage Mankin scores. The higher serum CTX-II concen-
tration illustrated that more type II collagen was
catabolized. The higher Mankin score indicated that the
degeneration of articular cartilage was more severe.
Tanishi et al. [21] found that individuals over 60 years
old with OA grade 3 or 4 according to X-rays had
Fig. 2 Mankin score of articular cartilage of rabbits in the OA and
control groups at various time points
Fig. 3 Serum CTX-II concentration in the OA and control groups at
various time points
Fig. 4 Serum COMP concentration in the OA and control groups at
various time points
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significantly higher urinary CTX-II values than those
with grade 0, 1, or 2. Jordan et al. [22] found that urinary
CTX-II was strongly associated with the presence and
severity of radiographic knee OA in men aged 59–
70 years. Accordingly, the dynamic detection of the
serum CTX-II concentration could reflect the severity of
OA articular cartilage lesions and facilitate the early
diagnosis of OA and predictions regarding the effect of
clinical treatment.
Similarly, Fernandes et al. [23] found that patients with
symptomatic knee OA present significantly higher serum
COMP levels compared to healthy controls and those
with non-symptomatic narrowings of the articular space.
El-Arman et al. [24] reported that the serum and
synovial fluid COMP levels are elevated and positively
correlated with radiological joint damage in OA. Fur-
thermore, Verma et al. [14] performed a case-control
study to estimate the association of COMP with knee
OA and found that the median (range) serum COMP
levels are higher in OA patients than in control subjects.
In our study, the serum COMP concentration of the OA
group was also elevated compared with that of the
control group at week 2 after surgery. At other time
points, the serum COMP concentrations were also
higher in the OA group than in the control group. Simi-
lar results were reported by Zuo et al. [12]. These results
illustrated that the serum COMP concentration in the
OA group was elevated at the early stage of OA and in-
creased during the progression of OA. We also found
that the increase in the serum COMP concentration was
gradual in the OA group, and no peak was detected dur-
ing the 12-week study.
We also investigated the correlation between the
serum COMP concentration and the severity of articular
cartilage degeneration. We detected a positive correl-
ation between the serum COMP concentration and the
Mankin score of the corresponding articular cartilage in
the OA group during the 12-week study. Specifically,
higher serum COMP concentrations were associated
with higher Mankin scores for the corresponding articular
cartilage. Higher serum concentration of CTX-II indicated
that more type II collagen was metabolized. Lai et al. [25]
reported that the serum COMP fragment concentration is
highly correlated with the severity of OA and the progres-
sion of surgically induced OA in murine models. Clark
et al. [15] demonstrated that in a population-based sam-
ple, serum COMP concentrations could distinguish an
OA-affected subgroup from an unaffected subgroup and
could reflect disease severity and multiple joint involve-
ment in OA. Based on previous results and those of this
study, the early dynamic detection of serum COMP con-
centrations could be used to monitor OA severity and to
help diagnose OA at an early stage.
As biomarkers, the CTX-II and COMP concentrations
could reflect the degree of type II collagen degeneration.
However, the results of in vitro and ex vivo human
cartilage experiments suggested that CTX-II is released
by different enzymatic pathways; accordingly, CTX-II
alone only partially reflects overall cartilage collagen
Fig. 5 Correlation between the serum concentrations of COMP and CTX-II
Fig. 6 Correlation between the serum concentration of CTX-II and
the Mankin score of the corresponding articular cartilage
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degradation [13]. Furthermore, Dodge et al. [26] demon-
strated that a small amount of COMP is produced by
several mesenchymal cells, including synoviocytes and
dermal fibroblasts. We found that the serum concentra-
tions of CTX-II and COMP were positively correlated
during the 12-week study. Therefore, the combined ana-
lysis of serum CTX-II and COMP concentrations could
provide complementary information on disease develop-
ment in OA and could be used to more accurately judge
the severity of OA and diagnose it at an early stage.
This was one of few studies evaluating the value of
CTX-II and COMP as biomarkers for the early diagnosis
of OA and estimations of disease severity. This study
had some limitations. The 12-week longitudinal study
was not sufficiently long; accordingly, changes in CTX-II
and COMP at the end stage of the disease were not
observed. We only performed a histological analysis of
medial femoral condyles, not including the lateral fem-
oral condyle and tibial plateau. However, the results are
reliable because some scientific and effective measures
were taken in this study, such as an appropriate sample
size, random grouping, sham-operation control, repeating,
and blinding.
Conclusions
The serum concentrations of CTX-II and COMP were
significantly higher in the OA group than in the control
group. The serum CTX-II and COMP concentrations
increased as OA progressed. There was a positive rela-
tionship between the serum CTX-II and COMP con-
centrations and the Mankin score of the corresponding
articular cartilage during OA progression. The serum
concentrations of CTX-II and COMP were positively
correlated. The dynamic combined detection of serum
CTX-II and COMP concentrations has important applica-
tions for the early diagnosis of OA and the determination
of OA severity.
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